DUO-Pharma SRL
DUO-Pharma reported total assets of 479,265 € at the end of the 2025 financial year (annual accounts filed with the NBB on 31 Jul 2026).
The score of DUO-Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -55 % Total assets -17 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
DUO-Pharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 28,181 € | ||||
| Equity | 61,181 € | ||||
| Cash | 102,246 € | ||||
| EBITDA | 95,585 € | ||||
| Total assets | 479,265 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Jul 2026
- Year ended 31 Dec 2024filed on 14 Jul 2025
- Year ended 31 Dec 2023filed on 23 Aug 2024
- Year ended 31 Dec 2022filed on 11 Jul 2023
- Year ended 31 Dec 2021filed on 13 Jul 2022
DUO-Pharma's financial analysis
- Solvency12.8%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of DUO-Pharma
DUO-Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0651.704.002
- VAT number
- BE0651704002
- Peppol
- Registered · 0208:0651704002 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 07 Apr 2016
- Registered office
- 1350 Orp-Jauche
- Latest accounts
- 2025 · filed on 31 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
DUO-Pharma (SRL) has been based in Orp-Jauche since 2016, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 28,181 € and equity of 61,181 €; its revenue is not published. Its solvency stands at 12.8%, below the median of its sector (41.5%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to DUO-Pharma
Companies in the same business, of comparable size and area, outside its group.
- Apotheek De Vijzel Retail sale of pharmaceutical products Zoersel · balance sheet 509,493 €
- Marc Thoné Retail sale of pharmaceutical products Antwerp · balance sheet 93,815 €
- Pharmacie Broman Retail sale of pharmaceutical products Montigny-le-Tilleul · balance sheet 481,857 €
- Les 3 Filles Retail sale of pharmaceutical products Schaerbeek · balance sheet 786,130 €
- Pharmaela Retail sale of pharmaceutical products Quaregnon · balance sheet 286,114 €
- Medicuro Retail sale of pharmaceutical products Stekene · balance sheet 457,159 €
- Smets Pharma Retail sale of pharmaceutical products Lier · balance sheet 452,862 €
- LNR Retail sale of pharmaceutical products Kasterlee · balance sheet 516,544 €
Frequently asked questions about DUO-Pharma
What is the revenue of DUO-Pharma?
DUO-Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of DUO-Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0651704002 for DUO-Pharma, if the company is VAT-registered. Its company number (CBE) is 0651.704.002.
Where is the registered office of DUO-Pharma?
According to the CBE register, the registered office of DUO-Pharma is in 1350 Orp-Jauche.
What is the equity of DUO-Pharma?
At the close of the 2025 financial year, the equity of DUO-Pharma amounts to 61,181 €, a solvency of 12.8% of total assets.
Who manages DUO-Pharma?
The register lists 2 active mandates at DUO-Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of DUO-Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →